Empowering CML Caregivers: Strategies and Support Systems

Opinion
Video

Experts on chronic myeloid leukemia discuss how caregivers can collaborate with the health care team and support newly diagnosed patients.

This program was made possible with support from Novartis Pharmaceuticals.

Video content above is prompted by the following questions:

  • In your work with caregivers, how have you seen them collaborate with the healthcare team to support newly diagnosed patients with CML?
    • Are there any specific aspects of CML management where caregiver support is particularly impactful?
    • Are there any resources or support groups you recommend for caregivers of patients with CML?
Recent Videos
4 experts in this video
4 experts in this video
4 experts in this video
4 experts in this video
Yale’s COPPER Center aims to address disparities and out-of-pocket costs for patients, thereby improving the delivery of complex cancer treatment.
Non-Hodgkin lymphoma and other indolent forms of disease may require sequencing new treatments for years or decades, said Scott Huntington, MD, MPH, MSc.
Fixed-duration therapy may be more suitable for younger patients, while continuous therapy may benefit those who are older with more comorbidities.
Determining the molecular characteristics of one’s disease may influence the therapy employed in the first line as well as subsequent settings.
4 experts in this video
4 experts in this video
Related Content